1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.11%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
294.55%
Gross profit growth above 1.5x MAXN's 73.39%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-215.39%
Negative EBIT growth while MAXN is at 71.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-262.81%
Negative operating income growth while MAXN is at 66.50%. Joel Greenblatt would press for urgent turnaround measures.
-150.75%
Negative net income growth while MAXN stands at 73.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-149.67%
Negative EPS growth while MAXN is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-149.67%
Negative diluted EPS growth while MAXN is at 73.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.62%
Share change of 0.62% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.62%
Diluted share change of 0.62% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
120.36%
OCF growth 1.25-1.5x MAXN's 93.92%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
103.24%
FCF growth 1.25-1.5x MAXN's 91.23%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
No Data
No Data available this quarter, please select a different quarter.
657.47%
Positive 5Y CAGR while MAXN is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
53.03%
3Y revenue/share CAGR above 1.5x MAXN's 7.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
127.48%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
-88.02%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
-2819.21%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1330.25%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
72.75%
Positive 5Y equity/share CAGR while MAXN is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-3.62%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.64%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.06%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.28%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-21.84%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
18.12%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-16.98%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-15.99%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.